Cargando…

Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study

Objective To evaluate differences in first manifestations of cardiovascular disease between men and women in a competing risks framework. Design Prospective population based cohort study. Setting People living in the community in Rotterdam, the Netherlands. Participants 8419 participants (60.9% wome...

Descripción completa

Detalles Bibliográficos
Autores principales: Leening, Maarten J G, Ferket, Bart S, Steyerberg, Ewout W, Kavousi, Maryam, Deckers, Jaap W, Nieboer, Daan, Heeringa, Jan, Portegies, Marileen L P, Hofman, Albert, Ikram, M Arfan, Hunink, M G Myriam, Franco, Oscar H, Stricker, Bruno H, Witteman, Jacqueline C M, Roos-Hesselink, Jolien W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233917/
https://www.ncbi.nlm.nih.gov/pubmed/25403476
http://dx.doi.org/10.1136/bmj.g5992
_version_ 1782344773427789824
author Leening, Maarten J G
Ferket, Bart S
Steyerberg, Ewout W
Kavousi, Maryam
Deckers, Jaap W
Nieboer, Daan
Heeringa, Jan
Portegies, Marileen L P
Hofman, Albert
Ikram, M Arfan
Hunink, M G Myriam
Franco, Oscar H
Stricker, Bruno H
Witteman, Jacqueline C M
Roos-Hesselink, Jolien W
author_facet Leening, Maarten J G
Ferket, Bart S
Steyerberg, Ewout W
Kavousi, Maryam
Deckers, Jaap W
Nieboer, Daan
Heeringa, Jan
Portegies, Marileen L P
Hofman, Albert
Ikram, M Arfan
Hunink, M G Myriam
Franco, Oscar H
Stricker, Bruno H
Witteman, Jacqueline C M
Roos-Hesselink, Jolien W
author_sort Leening, Maarten J G
collection PubMed
description Objective To evaluate differences in first manifestations of cardiovascular disease between men and women in a competing risks framework. Design Prospective population based cohort study. Setting People living in the community in Rotterdam, the Netherlands. Participants 8419 participants (60.9% women) aged ≥55 and free from cardiovascular disease at baseline. Main outcome measures First diagnosis of coronary heart disease (myocardial infarction, revascularisation, and coronary death), cerebrovascular disease (stroke, transient ischaemic attack, and carotid revascularisation), heart failure, or other cardiovascular death; or death from non-cardiovascular causes. Data were used to calculate lifetime risks of cardiovascular disease and its first incident manifestations adjusted for competing non-cardiovascular death. Results During follow-up of up to 20.1 years, 2888 participants developed cardiovascular disease (826 coronary heart disease, 1198 cerebrovascular disease, 762 heart failure, and 102 other cardiovascular death). At age 55, overall lifetime risks of cardiovascular disease were 67.1% (95% confidence interval 64.7% to 69.5%) for men and 66.4% (64.2% to 68.7%) for women. Lifetime risks of first incident manifestations of cardiovascular disease in men were 27.2% (24.1% to 30.3%) for coronary heart disease, 22.8% (20.4% to 25.1%) for cerebrovascular disease, 14.9% (13.3% to 16.6%) for heart failure, and 2.3% (1.6% to 2.9%) for other deaths from cardiovascular disease. For women the figures were 16.9% (13.5% to 20.4%), 29.8% (27.7% to 31.9%), 17.5% (15.9% to 19.2%), and 2.1% (1.6% to 2.7%), respectively. Differences in the number of events that developed over the lifespan in women compared with men (per 1000) were −7 for any cardiovascular disease, −102 for coronary heart disease, 70 for cerebrovascular disease, 26 for heart failure, and −1 for other cardiovascular death; all outcomes manifested at a higher age in women. Patterns were similar when analyses were restricted to hard atherosclerotic cardiovascular disease outcomes, but absolute risk differences between men and women were attenuated for both coronary heart disease and stroke. Conclusions At age 55, though men and women have similar lifetime risks of cardiovascular disease, there are considerable differences in the first manifestation. Men are more likely to develop coronary heart disease as a first event, while women are more likely to have cerebrovascular disease or heart failure as their first event, although these manifestations appear most often at older ages.
format Online
Article
Text
id pubmed-4233917
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BMJ Publishing Group Ltd.
record_format MEDLINE/PubMed
spelling pubmed-42339172014-11-21 Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study Leening, Maarten J G Ferket, Bart S Steyerberg, Ewout W Kavousi, Maryam Deckers, Jaap W Nieboer, Daan Heeringa, Jan Portegies, Marileen L P Hofman, Albert Ikram, M Arfan Hunink, M G Myriam Franco, Oscar H Stricker, Bruno H Witteman, Jacqueline C M Roos-Hesselink, Jolien W BMJ Research Objective To evaluate differences in first manifestations of cardiovascular disease between men and women in a competing risks framework. Design Prospective population based cohort study. Setting People living in the community in Rotterdam, the Netherlands. Participants 8419 participants (60.9% women) aged ≥55 and free from cardiovascular disease at baseline. Main outcome measures First diagnosis of coronary heart disease (myocardial infarction, revascularisation, and coronary death), cerebrovascular disease (stroke, transient ischaemic attack, and carotid revascularisation), heart failure, or other cardiovascular death; or death from non-cardiovascular causes. Data were used to calculate lifetime risks of cardiovascular disease and its first incident manifestations adjusted for competing non-cardiovascular death. Results During follow-up of up to 20.1 years, 2888 participants developed cardiovascular disease (826 coronary heart disease, 1198 cerebrovascular disease, 762 heart failure, and 102 other cardiovascular death). At age 55, overall lifetime risks of cardiovascular disease were 67.1% (95% confidence interval 64.7% to 69.5%) for men and 66.4% (64.2% to 68.7%) for women. Lifetime risks of first incident manifestations of cardiovascular disease in men were 27.2% (24.1% to 30.3%) for coronary heart disease, 22.8% (20.4% to 25.1%) for cerebrovascular disease, 14.9% (13.3% to 16.6%) for heart failure, and 2.3% (1.6% to 2.9%) for other deaths from cardiovascular disease. For women the figures were 16.9% (13.5% to 20.4%), 29.8% (27.7% to 31.9%), 17.5% (15.9% to 19.2%), and 2.1% (1.6% to 2.7%), respectively. Differences in the number of events that developed over the lifespan in women compared with men (per 1000) were −7 for any cardiovascular disease, −102 for coronary heart disease, 70 for cerebrovascular disease, 26 for heart failure, and −1 for other cardiovascular death; all outcomes manifested at a higher age in women. Patterns were similar when analyses were restricted to hard atherosclerotic cardiovascular disease outcomes, but absolute risk differences between men and women were attenuated for both coronary heart disease and stroke. Conclusions At age 55, though men and women have similar lifetime risks of cardiovascular disease, there are considerable differences in the first manifestation. Men are more likely to develop coronary heart disease as a first event, while women are more likely to have cerebrovascular disease or heart failure as their first event, although these manifestations appear most often at older ages. BMJ Publishing Group Ltd. 2014-11-17 /pmc/articles/PMC4233917/ /pubmed/25403476 http://dx.doi.org/10.1136/bmj.g5992 Text en © Leening et al 2014 http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Research
Leening, Maarten J G
Ferket, Bart S
Steyerberg, Ewout W
Kavousi, Maryam
Deckers, Jaap W
Nieboer, Daan
Heeringa, Jan
Portegies, Marileen L P
Hofman, Albert
Ikram, M Arfan
Hunink, M G Myriam
Franco, Oscar H
Stricker, Bruno H
Witteman, Jacqueline C M
Roos-Hesselink, Jolien W
Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study
title Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study
title_full Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study
title_fullStr Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study
title_full_unstemmed Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study
title_short Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study
title_sort sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233917/
https://www.ncbi.nlm.nih.gov/pubmed/25403476
http://dx.doi.org/10.1136/bmj.g5992
work_keys_str_mv AT leeningmaartenjg sexdifferencesinlifetimeriskandfirstmanifestationofcardiovasculardiseaseprospectivepopulationbasedcohortstudy
AT ferketbarts sexdifferencesinlifetimeriskandfirstmanifestationofcardiovasculardiseaseprospectivepopulationbasedcohortstudy
AT steyerbergewoutw sexdifferencesinlifetimeriskandfirstmanifestationofcardiovasculardiseaseprospectivepopulationbasedcohortstudy
AT kavousimaryam sexdifferencesinlifetimeriskandfirstmanifestationofcardiovasculardiseaseprospectivepopulationbasedcohortstudy
AT deckersjaapw sexdifferencesinlifetimeriskandfirstmanifestationofcardiovasculardiseaseprospectivepopulationbasedcohortstudy
AT nieboerdaan sexdifferencesinlifetimeriskandfirstmanifestationofcardiovasculardiseaseprospectivepopulationbasedcohortstudy
AT heeringajan sexdifferencesinlifetimeriskandfirstmanifestationofcardiovasculardiseaseprospectivepopulationbasedcohortstudy
AT portegiesmarileenlp sexdifferencesinlifetimeriskandfirstmanifestationofcardiovasculardiseaseprospectivepopulationbasedcohortstudy
AT hofmanalbert sexdifferencesinlifetimeriskandfirstmanifestationofcardiovasculardiseaseprospectivepopulationbasedcohortstudy
AT ikrammarfan sexdifferencesinlifetimeriskandfirstmanifestationofcardiovasculardiseaseprospectivepopulationbasedcohortstudy
AT huninkmgmyriam sexdifferencesinlifetimeriskandfirstmanifestationofcardiovasculardiseaseprospectivepopulationbasedcohortstudy
AT francooscarh sexdifferencesinlifetimeriskandfirstmanifestationofcardiovasculardiseaseprospectivepopulationbasedcohortstudy
AT strickerbrunoh sexdifferencesinlifetimeriskandfirstmanifestationofcardiovasculardiseaseprospectivepopulationbasedcohortstudy
AT wittemanjacquelinecm sexdifferencesinlifetimeriskandfirstmanifestationofcardiovasculardiseaseprospectivepopulationbasedcohortstudy
AT rooshesselinkjolienw sexdifferencesinlifetimeriskandfirstmanifestationofcardiovasculardiseaseprospectivepopulationbasedcohortstudy